2.4.2.2 The provision of adequate information relating to food to enable consumers to make informed choices No issues have been identified for this Application relevant to this objective. The labelling requirements for this processing aid are discussed in Section 2.2.2 – Labelling considerations. 2.4.2.3 The prevention of misleading or deceptive conduct No issues were identified for this Application relevant to this objective. 2.4.3 Subsection 18(2) considerations FSANZ has also had regard to: the need for standards to be based on risk analysis using the best available scientific evidence FSANZ has used the best available scientific evidence to conduct the risk analysis which is provided in SD1. The Applicant submitted a dossier of evidence as part of their Application. Other technical information including scientific literature was also used in assessing the Application. the promotion of consistency between domestic and international food standards Section 1.3.1 describes the current permissions for various bacteriophages in different countries. The attributes of using bacteriophages as a component of food safety management systems to control bacterial contamination on foods has been described. the desirability of an efficient and internationally competitive food industry The food industry will make their own economic decisions, taking account of costs and benefits of using phage as part of their hurdle technology to control Salmonella to determine if it benefits their business. the promotion of fair trading in food The Salmonella phage has been permitted and assessed as safe in other countries. FSANZ’s own risk analysis has confirmed this finding. It is therefore appropriate that the local Australian and New Zealand food industries have access to the same technology which may have benefits to industry and consumers. any written policy guidelines formulated by the Ministerial Council The Addition to Food of Substances other than Vitamins and Minerals includes specific order policy principles for substances added to achieve a solely technological function, such as processing aids. These specific order policy principles state that permission should be granted where: the purpose for adding the substance can be articulated clearly by the manufacturer as achieving a solely technological function (i.e. the ‘stated purpose’) the addition of the substance to food is safe for human consumption the amounts added are consistent with achieving the technological function the substance is added in a quantity and a form which is consistent with delivering the stated purpose no nutrition, health or related claims are to be made in regard to the substance.
Food Standards (Application A1111 – Bacteriophage S16 & FO1a as a Processing Aid) Variation The Board of Food Standards Australia New Zealand gives notice of the making of this variation under section 92 of the Food Standards Australia New Zealand Act 1991. The variation commences on the date specified in clause 3 of this variation. Dated [To be completed by Standards Management Officer] Standards Management Officer Delegate of the Board of Food Standards Australia New Zealand Note: This variation will be published in the Commonwealth of Australia Gazette No. FSC XX on XX Month 20XX. This means that this date is the gazettal date for the purposes of clause 3 of the variation. 1 Name This instrument is the Food Standards (Application A1111 – Bacteriophage S16 & FO1a as a Processing Aid) Variation. 2 Variation to a Standard in the Australia New Zealand Food Standards Code The Schedule varies a Standard in the Australia New Zealand Food Standards Code. 3 Commencement This instrument commences on gazettal. Schedule [1] Schedule 3 is varied by [1.1] inserting in the table to subsection S3—2(2) in alphabetical order “ Salmonella phage preparation (S16 and FO1a) section S3—33 ” [1.2] inserting after section S3—32 “S3—33 Specifications for Salmonella phage preparation (S16 and FO1a) (1) In this section: a preparation means a Salmonella phage preparation (S16 and FO1a). Salmonella phage preparation (S16 and FO1a) means a solution of a 1:1 blend of Salmonella phage S16 and Salmonella phage FO1a. (2) Salmonella phage S16 in a preparation must comply with the specification in